SCHEMBL2599566

SCHEMBL2599566

C[C@H](CC(=O)O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL791253 1.00
SCHEMBL17164603 1.00 CYP1A2 (0.55)
SCHEMBL105210 1.00
SCHEMBL105145 0.97 CYP1A2 (0.52)
Ammonia Solution, Strong SCHEMBL20582897 0.97 TDP1 (0.55)
SCHEMBL6737976 0.97 CYP1A2 (0.52)
SCHEMBL10884759 0.97 CYP1A2 (0.52)
Hydrochloric Acid SCHEMBL8052774 0.97 CYP1A2 (0.52)
SCHEMBL106819 0.97 CYP1A2 (0.52)
Ethane SCHEMBL5873454 0.97 CYP1A2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109336887-B Benzimidazole chiral heterocyclic compound and preparation method and application thereof 中山大学 2021-12-17 CN claimed
CN-109336887-A A kind of benzimidazole and chiral heterocycle class compound and its preparation method and application 中山大学 2019-02-15 CN claimed
CN-104610363-B Phosphorous amide ligand and its preparation method and application 中山大学 2018-04-10 CN claimed
CN-106831862-A Axial chirality monophosphorus ligand of one class chirality bridging and preparation method thereof 中山大学 2017-06-13 CN claimed
CN-102875601-B Phosphine-oxazoline ligand and ionic type metal title complex thereof and its enantiomorph or raceme preparation method and application SUN YAT-SEN UNIVERSITY (CN) 2016-03-09 CN claimed
CN-102532196-B Phosphine ligands and enantiomorph or raceme and preparation method thereof SUN YAT-SEN UNIVERSITY (CN) 2015-09-02 CN claimed
CN-104610363-A Phosphoramidite ligand as well as preparation method and application thereof UNIV SUN YAT SEN 2015-05-13 CN claimed
CN-102875601-A Preparation method and application for phosphine-oxazoline ligand, and ionic metal complex, enantiomer or racemate thereof UNIV SUN YAT SEN 2013-01-16 CN claimed
EP-1504002-B1 METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE BETA-AMINOKETONES AND OPTICALLY ACTIVE 1,3-AMINOALCOHOLS SANOFI AVENTIS DEUTSCHLAND (DE) 2012-12-19 EP claimed
CN-102532196-A Phosphine ligand and enantiomer or racemic body thereof and preparation methods thereof UNIV SUN YAT SEN 2012-07-04 CN claimed
CN-102516300-A Phosphine ligands, enantiomers or racemates thereof, and preparation methods of above UNIV SUN YAT SEN 2012-06-27 CN claimed
WO-2011145019-A1 IMPROVED PROCESS FOR DIPHENYLPROPYLAMINE DERIVATIVES ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) 2011-11-24 WO claimed
US-7161008-B2 Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them Sanofi - Aventis Deutschland GmbH (DE) 2007-01-09 US claimed
US-20040030145-A1 Optically active B-aminoketones, optically active 1,3-amino alcohols and processes for preparing them AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-02-12 US claimed
EP-0481712-B1 Process for production of optically active methylsuccinic acid NIPPON OIL CO LTD (JP) 1996-04-24 EP claimed
US-5217887-A PROCESS FOR PRODUCTION OF (R) METHYLSUCCINIC ACID FROM SQUALENE USING CANDIDA LIPOLYTICA NIPPON OIL CO., LTD. (JP) 1993-06-08 US claimed
US-4061657-A Process for preparing a 2(R) or 2(S) tricyclic lactone glycol THE UPJOHN COMPANY (US) 1977-12-06 US claimed
US-4048193-A Process for bicyclic lactone dials THE UPJOHN COMPANY (US) 1977-09-13 US claimed
US-3953473-A Tricyclic lactone glycol sulfonates THE UPJOHN COMPANY (US) 1976-04-27 US claimed
US-20250339569-A1 CARBONIC ANHYDRASE IX LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-11-06 US disclosed
CN-119842643-A Alkene reductase mutant and application thereof in synthesis of (R) -2-methyl succinic acid dimethyl ester 中国科学院天津工业生物技术研究所 2025-04-18 CN disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-20230278953-A1 WATER SOLUBLE PRODRUGS OF PTBA FOR USE IN HDAC INHIBITION AND ENHANCING RENAL RECOVERY FOLLOWING ACUTE KIDNEY INJURY KLOTHO THERAPEUTICS, INC. 2023-09-07 US disclosed
US-11535660-B1 Modulators of G-protein coupled receptors Cannot Therapeutics, Inc. (US) 2022-12-27 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-111944515-B Circular polarization luminescent material and preparation method and application thereof 中国科学院化学研究所 2022-05-10 CN disclosed
US-11236122-B2 Triterpene amine derivatives DFH THERAPEUTICS (US) 2022-02-01 US disclosed
CN-109336887-B Benzimidazole chiral heterocyclic compound and preparation method and application thereof 中山大学 2021-12-17 CN disclosed
US-20210289794-A1 COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE FLAGSHIP PIONEERING INNOVATIONS V, INC. 2021-09-23 US disclosed
US-20210253627-A1 TRITERPENE AMINE DERIVATIVES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2021-08-19 US disclosed
CN-112236161-A Modulators of G protein-coupled receptors 卡莫特治疗学股份有限公司 2021-01-15 CN disclosed
CN-106831862-B Chiral bridged axial chiral monophosphine ligand and preparation method thereof 中山大学 2021-01-15 CN disclosed
CN-109336887-A A kind of benzimidazole and chiral heterocycle class compound and its preparation method and application 中山大学 2019-02-15 CN disclosed
CN-104610363-B Phosphorous amide ligand and its preparation method and application 中山大学 2018-04-10 CN disclosed
CN-106831862-A Axial chirality monophosphorus ligand of one class chirality bridging and preparation method thereof 中山大学 2017-06-13 CN disclosed
US-20160271082-A1 BACTERIAL EFFLUX PUMP INHIBITORS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-09-22 US disclosed
US-20160271081-A1 BACTERIAL EFFLUX PUMP INHIBITORS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-09-22 US disclosed
US-20160176906-A1 Chemical Compounds ASTRAZENECA AB (SE) 2016-06-23 US disclosed
US-9248140-B2 Chemical compounds ASTRAZENECA AB (SE) 2016-02-02 US disclosed
US-20150328239-A1 Chemical Compounds ASTRAZENECA AB (SE) 2015-11-19 US disclosed
US-20150315154-A1 HISTIDINYLATED CATIONIC AMPHIPHILES, PROCESS FOR PREPARATION THEROF AND THEIR LIPOSOMAL FORMULATION COUNCIL SCIENT IND RES (IN) 2015-11-05 US disclosed
US-9145425-B2 Cephem compound having catechol group SHIONOGI & CO., LTD. (JP) 2015-09-29 US disclosed
CN-102532196-B Phosphine ligands and enantiomorph or raceme and preparation method thereof SUN YAT-SEN UNIVERSITY (CN) 2015-09-02 CN disclosed
US-20150197506-A1 NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF OLEMA PHARMACEUTICALS, INC. (US) 2015-07-16 US disclosed
US-20150197506-A1 NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF OLEMA PHARMACEUTICALS, INC. (US) 2015-07-16 US disclosed
US-20150197506-A1 NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF OLEMA PHARMACEUTICALS, INC. (US) 2015-07-16 US disclosed
CN-104610363-A Phosphoramidite ligand as well as preparation method and application thereof UNIV SUN YAT SEN 2015-05-13 CN disclosed
US-9018244-B2 Benzopyran compounds, compositions and uses thereof OLEMA PHARMACEUTICALS, INC. (US) 2015-04-28 US disclosed
US-9018244-B2 Benzopyran compounds, compositions and uses thereof OLEMA PHARMACEUTICALS, INC. (US) 2015-04-28 US disclosed
US-9018381-B2 Chemical compounds ASTRAZENECA AB (SE) 2015-04-28 US disclosed
US-9018244-B2 Benzopyran compounds, compositions and uses thereof OLEMA PHARMACEUTICALS, INC. (US) 2015-04-28 US disclosed
CN-104169266-A Novel benzopyran compounds, compositions and uses thereof OLEMA PHARMACEUTICALS INC 2014-11-26 CN disclosed
US-8883773-B2 Cephem compound having pseudo-catechol group SHIONOGI & CO., LTD. (JP) 2014-11-11 US disclosed
EP-2791128-A1 NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF Olema Pharmaceuticals, Inc. (US) 2014-10-22 EP disclosed
US-20130310344-A1 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS ASTRAZENECA AB (UK) 2013-11-21 US disclosed
US-20130178445-A1 Novel Benzopyran Compounds, Compositions and Uses Thereof OLEMA PHARMACEUTICALS, INC. (US) 2013-07-11 US disclosed
US-20130178445-A1 Novel Benzopyran Compounds, Compositions and Uses Thereof OLEMA PHARMACEUTICALS, INC. (US) 2013-07-11 US disclosed
US-20130178445-A1 Novel Benzopyran Compounds, Compositions and Uses Thereof OLEMA PHARMACEUTICALS, INC. (US) 2013-07-11 US disclosed
WO-2013090921-A1 NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF OLEMA PHARMACEUTICALS, INC. (US) 2013-06-20 WO disclosed
WO-2013090921-A1 NOVEL BENZOPYRAN COMPOUNDS, COMPOSITIONS AND USES THEREOF OLEMA PHARMACEUTICALS, INC. (US) 2013-06-20 WO disclosed
US-20130102583-A1 CEPHEM COMPOUND HAVING CATECHOL GROUP SHIONOGI & CO., LTD. (JP) 2013-04-25 US disclosed
CN-102875601-A Preparation method and application for phosphine-oxazoline ligand, and ionic metal complex, enantiomer or racemate thereof UNIV SUN YAT SEN 2013-01-16 CN disclosed
CN-102532196-A Phosphine ligand and enantiomer or racemic body thereof and preparation methods thereof UNIV SUN YAT SEN 2012-07-04 CN disclosed
CN-102516300-A Phosphine ligands, enantiomers or racemates thereof, and preparation methods of above UNIV SUN YAT SEN 2012-06-27 CN disclosed
US-20120035134-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2012-02-09 US disclosed
WO-2011145019-A1 IMPROVED PROCESS FOR DIPHENYLPROPYLAMINE DERIVATIVES ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) 2011-11-24 WO disclosed
EP-1758844-B1 PHOSPHINE-PHOSPHORAMIDITE COMPOUNDS JOHNSON MATTHEY PLC (GB) 2010-12-15 EP disclosed
EP-1501819-B1 ESTROGEN RECEPTOR MODULATORS MERCK SHARP & DOHME (US) 2010-09-15 EP disclosed
US-7512309-B2 Polymer composition, plastic optical fiber, plastic optical fiber cable, and method for manufacturing plastic optical fiber MITSUBISHI RAYON CO, LTD. (JP) 2009-03-31 US disclosed
EP-1758845-B1 PREPARATION OF AMINOPHOSPHINES JOHNSON MATTHEY PLC (GB) 2008-12-03 EP disclosed
US-20080166091-A1 Polymer Composition, Plastic Optical Fiber, Plastic Optical Fiber Cable, and Method for Manufacturing Plastic Optical Fiber MITSUBISHI RAYON CO., LTD. (JP) 2008-07-10 US disclosed
CN-101087820-A Polymer composition, plastic optical fiber, plastic optical cable, and method for producing plastic optical fiber MITSUBISHI RAYON CO (JP) 2007-12-12 CN disclosed
EP-1834968-A1 POLYMER COMPOSITION, PLASTIC OPTICAL FIBER, PLASTIC OPTICAL FIBER CABLE AND METHOD FOR PRODUCING PLASTIC OPTICAL FIBER Mitsubishi Rayon Co., Ltd. (JP) 2007-09-19 EP disclosed
EP-1626949-B1 SUPPORTED METAL-PHOSPHINE-AMINOPHOSPHINE CATALYSTS EASTMAN CHEM CO (US) 2007-03-21 EP disclosed
EP-1758844-A1 PHOSPHINE-PHOSPHORAMIDITE COMPOUNDS EASTMAN CHEMICAL COMPANY (US) 2007-03-07 EP disclosed
EP-1758845-A2 PREPARATION OF AMINOPHOSPHINES EASTMAN CHEMICAL COMPANY (US) 2007-03-07 EP disclosed
US-7161008-B2 Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them Sanofi - Aventis Deutschland GmbH (DE) 2007-01-09 US disclosed
US-7138426-B2 Estrogen receptor modulators MERCK & CO., INC. (US) 2006-11-21 US disclosed
EP-1626949-A1 SUPPORTED METAL-PHOSPHINE-AMINOPHOSPHINE CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2006-02-22 EP disclosed
WO-2006012045-A1 PHOSPHINE-PHOSPHORAMIDITE COMPOUNDS EASTMAN CHEMICAL COMPANY (US) 2006-02-02 WO disclosed
WO-2006012046-A2 PREPARATION OF AMINOPHOSPHINES EASTMAN CHEMICAL COMPANY (US) 2006-02-02 WO disclosed
US-20050234245-A1 Estrogen receptor modulators MERCK SHARP & DOHME CORP. 2005-10-20 US disclosed
US-6936718-B2 Preparation of rotamer mixtures of pharmaceutical salts SCHERING CORPORATION (US) 2005-08-30 US disclosed
US-20050176758-A1 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors GILEAD SCIENCES, INC. 2005-08-11 US disclosed
US-6906213-B1 Preparation of aminophosphines EASTMAN CHEMICAL COMPANY (US) 2005-06-14 US disclosed
US-6906212-B1 Phosphine-phosphoramidite compounds EASTMAN CHEMICAL COMPANY (US) 2005-06-14 US disclosed
CN-1599610-A Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aid SCHERING CORP (US) 2005-03-23 CN disclosed
WO-2005019177-A1 AMINOPIPERIDINE AMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-03-03 WO disclosed
EP-1503973-A2 HYDROGENATION IN SUPERCRITICAL C1-4 FLUORINATED HYDROCARBONS Advanced Phytonics Limited (GB) 2005-02-09 EP disclosed
US-20040260126-A1 Supported metal-phosphine-aminophosphine catalysts EASTMAN CHEMICAL COMPANY 2004-12-23 US disclosed
WO-2004108651-A1 SUPPORTED METAL-PHOSPHINE-AMINOPHOSPHINE CATALYSTS EASTMAN CHEMICAL COMPANY (US) 2004-12-16 WO disclosed
EP-1448528-A2 PREPARATION OF PHARMACEUTICAL SALTS OF 4((Z)-(4-BROMOPHENYL)(ETHOXYIMINO)METHYL)-1'-((2,4-DIMETHYL-1-OXIDO-3-PYRIDINYL)CARBONYL)-4'-METHYL-1,4'BIPIPERIDINE AS CCR5-ANTAGONISTS FOR THE TREATMENT OF AIDS AND RELATED HIV INFECTIONS SCHERING CORPORATION (US) 2004-08-25 EP disclosed
US-6750213-B2 BONE DISORDERS; UROGENITAL SYSTEM DISORDERS; ANTICANCER AGENTS MERCK & CO., INC. 2004-06-15 US disclosed
US-20040044047-A1 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. 2004-03-04 US disclosed
US-20040030145-A1 Optically active B-aminoketones, optically active 1,3-amino alcohols and processes for preparing them AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-02-12 US disclosed
US-20030225132-A1 Heterocyclic salts such as 3-(3-Hydroxyphenyl)-2-(4-(2-(1-pyrrolidinium)ethoxyphenol)-2,3-dihydro-1,4 -benzoxathiin-6-ol hydrochloride salt, used as estrane agonists, for phrophylaxis of bone disorders DININNO FRANK P (US) 2003-12-04 US disclosed
WO-2003095084-A2 HYDROGENATION IN SUPERCRITICAL C1-4 FLUORINATED HYDROCARBONS ADVANCED PHYTONICS LIMITED (GB) 2003-11-20 WO disclosed
CN-1125808-C Process for preparation of dicarboxylic acid monoesters MITSUBISHI RAYON CO (JP) 2003-10-29 CN disclosed
WO-2003086388-A1 ESTROGEN RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-23 WO disclosed
WO-2003087073-A1 ESTROGEN RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-23 WO disclosed
WO-2003066593-A2 PREPARATION OF PHARMACEUTICAL SALTS OF 4 ( (Z) - (4-BROMOPHENYL) (ETHOXYIMINO) METHYL )-1'-( (2,4-DIMETHYL-1-OXIDO-3-PYRIDINYL) CARBONYL) -4'-METHYL-1,4' BIPIPERIDINE AS CCR5-ANTAGONISTS FOR THE TREATMENT OF AIDS AND RELATED HIV INFECTIONS SCHERING CORPORATION (US) 2003-08-14 WO disclosed
US-20030139446-A1 Preparation of pharmaceutical salts SCHERING CORPORATION 2003-07-24 US disclosed
US-6518438-B2 Reacting chemical intermediate with reducing agent; neuraminidase inhibitor GILEAD SCIENCES, INC. 2003-02-11 US disclosed
US-20020165226-A1 Estrogen receptor modulators MERCK & CO., INC. 2002-11-07 US disclosed
US-20020156300-A1 Preparation of cyclohexene carboxylate derivatives GILEAD SCIENCES, INC. 2002-10-24 US disclosed
US-20020058823-A1 Dehydrationg cyclohexylalcohol compound GILEAD SCIENCES, INC. 2002-05-16 US disclosed
US-6376674-B1 BACTERICIDES; VIRICIDES GILEAD SCIENCES, INC. 2002-04-23 US disclosed
US-6355830-B1 ESTER INTERCHANGE IN THE PRESENCE OF SOLVENTS A DICARBOXYLIC ACID MITSUBISHI RAYON CO., LTD. (JP) 2002-03-12 US disclosed
EP-0943600-B1 PROCESSES FOR THE PREPARATION OF DICARBOXYLIC ACID MONOESTERS MITSUBISHI RAYON CO (JP) 2002-01-02 EP disclosed
EP-1095022-A1 RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 2001-05-02 EP disclosed
US-6225341-B1 FOR INHIBITING NEURAMINIDASE; FOR THERAPY AND PROPHYLAXIS OF VIRUS INFECTION GILEAD SCIENCES, INC. 2001-05-01 US disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
US-6204398-B1 USEFUL AS INTERMEDIATES THAT ARE THEMSELVES USEFUL IN THE SYNTHESIS OF NEURAMINIDASE INHIBITORS GILEAD SCIENCES, INC. 2001-03-20 US disclosed
US-6172082-B1 TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS G. D. SEARLE & CO. 2001-01-09 US disclosed
US-6057459-A Preparation of carbocyclic compounds GILEAD SCIENCES, INC. (US) 2000-05-02 US disclosed
US-6034118-A ENZYME INHIBITOR GILEAD SCIENCES, INC. (US) 2000-03-07 US disclosed
EP-0976734-A2 Selective inhibitors of viral or bacterial neuraminidase GILEAD SCIENCES, INC. (US) 2000-02-02 EP disclosed
WO-2000002862-A1 RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 2000-01-20 WO disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed
CN-1237152-A Process for producing dicarboxylic acid monoesters MITSUBISHI RAYON CO (JP) 1999-12-01 CN disclosed
US-5994377-A NEURAMINIDASE INHIBITORS GILEAD SCIENCES, INC. (US) 1999-11-30 US disclosed
US-5958973-A Polyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitors GILEAD SCIENCES, INC. (US) 1999-09-28 US disclosed
EP-0943600-A1 PROCESSES FOR THE PREPARATION OF DICARBOXYLIC ACID MONOESTERS Mitsubishi Rayon Co., Ltd. (JP) 1999-09-22 EP disclosed
US-5952375-A NEURAMINIDASE INHIBITOR FOR INHIBITION OF VIRUSES, IN PARTICULAR INFLUENZA VIRUSES; FDA ORANGE BOOK LISTED PATENT FOR OSELTAMIVIR PHOSPHATE GILEAD SCIENCES, INC. (US) 1999-09-14 US disclosed
US-5886213-A CHEMICAL INTERMEDIATES USEFUL IN THE SYNTHESIS OF NEURAMINIDASE INHIBITORS GILEAD SCIENCES, INC. (US) 1999-03-23 US disclosed
US-5866601-A ACID CYCLOHEXENE DERIVATIVES, NEURAMINIDASE INHIBITORS SUCH AS OSELTAMIVIR GILEAD SCIENCES, INC. (US) 1999-02-02 US disclosed
US-5859284-A Preparation of carbocyclic compounds GILEAD SCIENCES, INC. (US) 1999-01-12 US disclosed
US-5811450-A DIAGNOSIS, TREATMENT OF HIV GILEAD SCIENCES, INC. (US) 1998-09-22 US disclosed
US-5763483-A NEURAMINIDASE INHIBITOR TREATING INFLUENZA VIRUS INFECTION; OSELTAMIVIR OR THE FREE ACID THEREOF; FDA ORANGE BOOK LISTED PATENT FOR OSELTAMIVIR PHOSPHATE GILEAD SCIENCES, INC. (US) 1998-06-09 US disclosed
US-5753659-A ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, ZENECA LIMITED (GB) 1998-05-19 US disclosed
US-5750754-A TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS ZENECA LIMITED (GB) 1998-05-12 US disclosed
US-5744481-A β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors G.D. SEARLE & CO. (US) 1998-04-28 US disclosed
US-5728701-A INHIBIT PLATELET AGGREGATION ZENECA LIMITED (GB) 1998-03-17 US disclosed
US-5705524-A ENZYME INHIBITORS; VIRICIDES GILEAD SCIENCES, INC. (US) 1998-01-06 US disclosed
EP-0796247-A1 (-)-(3R)-3-METHYL-4-(4-(4-(4-PYRIDYL)PIPERAZIN-1-YL]PHENOXY BUTYRIC ACID AS CELLULAR ADHESION INHIBITOR ZENECA LIMITED (GB) 1997-09-24 EP disclosed
CN-1155884-A (-)-(3R)-methyl-4-{-4-[4-(4-pyridyl)piperazin-1-YL]phenoxy} butyric acid as cellular adhesion inhibitor ZENECA LTD (GB) 1997-07-30 CN disclosed
US-5652242-A 3-METHYL-4-(4-(4-(4-PYRIDYL)PIPERAZIN-1-YL)PHENOXY)BURYIC ACID, AMIDE OR ESTER; INHIBITORS OF BINDING OF FIBRINOGEN TO GLYCOPROTEIN ZENECA LIMITED (GB) 1997-07-29 US disclosed
WO-1996038416-A1 (-)-(3R)-3-METHYL-4-{4-[4-(4-PYRIDYL)PIPERAZIN-1-YL]PHENOXY} BUTYRIC ACID AS CELLULAR ADHESION INHIBITOR ZENECA LIMITED (GB) 1996-12-05 WO disclosed
WO-1996026933-A1 NOVEL SELECTIVE INHIBITORS OF VIRAL OR BACTERIAL NEURAMINIDASES GILEAD SCIENCES, INC. (US) 1996-09-06 WO disclosed
EP-0715618-A1 HYDROXYETHYLAMINO SULPHONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1996-06-12 EP disclosed
WO-1996014314-A2 THIEPANE COMPOUNDS INHIBITING AND DETECTING HIV PROTEASE GILEAD SCIENCES, INC. (US) 1996-05-17 WO disclosed
EP-0481712-B1 Process for production of optically active methylsuccinic acid NIPPON OIL CO LTD (JP) 1996-04-24 EP disclosed
EP-0558673-B1 RETROVIRAL PROTEASE INHIBITORS MONSANTO CO (US) 1996-04-17 EP disclosed
US-5482947-A ENZYME INHIBITORS FOR HIV PROTEASE INHIBITION FROM UREA OR THIOUREA COMPOUNDS TALLEY JOHN J (US) 1996-01-09 US disclosed
EP-0666842-A1 HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1995-08-16 EP disclosed
EP-0656887-A1 HYDROXYETHYLAMINO SULFONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1995-06-14 EP disclosed
WO-1994010134-A1 HYDROXYETHYLAMINO SULFAMIC ACID DERIVATIVES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1994-05-11 WO disclosed
WO-1994004492-A1 HYDROXYETHYLAMINO SULFONAMIDES USEFUL AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1994-03-03 WO disclosed
WO-1993023368-A1 UREA-CONTAINING HYDROXYETHYLAMINE COMPOUNDS AS RETROVIRAL PROTEASE INHIBITORS G.D. SEARLE & CO. (US) 1993-11-25 WO disclosed
EP-0558603-A1 RETROVIRAL PROTEASE INHIBITORS MONSANTO COMPANY (US) 1993-09-08 EP disclosed
US-5217887-A PROCESS FOR PRODUCTION OF (R) METHYLSUCCINIC ACID FROM SQUALENE USING CANDIDA LIPOLYTICA NIPPON OIL CO., LTD. (JP) 1993-06-08 US disclosed
WO-1992008688-A1 RETROVIRAL PROTEASE INHIBITORS MONSANTO COMPANY (US) 1992-05-29 WO disclosed
EP-0481712-A2 Process for production of optically active methylsuccinic acid NIPPON OIL CO. LTD. (JP) 1992-04-22 EP disclosed
US-4464235-A Carrying out electromicrobial reductions BASF AKTIENGESELLSCHAFT (DE) 1984-08-07 US disclosed
US-4438033-A Steroidal chiral phosphines, methods for their preparation, catalytic systems containing them and catalytic processes in which they are used CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 1984-03-20 US disclosed
EP-0081149-A1 New steroidal chiral phosphines, methods for their preparation, catalytic systems containing them and catalytic processes in which they are used CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 1983-06-15 EP disclosed
US-4061657-A Process for preparing a 2(R) or 2(S) tricyclic lactone glycol THE UPJOHN COMPANY (US) 1977-12-06 US disclosed
US-4048193-A Process for bicyclic lactone dials THE UPJOHN COMPANY (US) 1977-09-13 US disclosed
US-4048193-A Process for bicyclic lactone dials THE UPJOHN COMPANY (US) 1977-09-13 US disclosed
US-3966751-A Oxazolidines of 4-oxo-tricyclo[5.1.02.5 ]octan-8-endo-carboxaldehyde, neopentyl glycol acetal THE UPJOHN COMPANY (US) 1976-06-29 US disclosed
US-3953473-A Tricyclic lactone glycol sulfonates THE UPJOHN COMPANY (US) 1976-04-27 US disclosed
US-3953473-A Tricyclic lactone glycol sulfonates THE UPJOHN COMPANY (US) 1976-04-27 US disclosed
US-3946046-A Resolution of prostaglandin intermediates by means of oxazolidines THE UPJOHN COMPANY (US) 1976-03-23 US disclosed
US-3879423-A Ethers UPJOHN CO 1975-04-22 US disclosed
US-3873570-A Lactones UPJOHN CO 1975-03-25 US disclosed
US-3818045-A CERTAIN BICYCLIC LACTONE DIOLS UPJOHN CO 1974-06-18 US disclosed
US-3818045-A CERTAIN BICYCLIC LACTONE DIOLS UPJOHN CO 1974-06-18 US disclosed